CXCR4 overexpression in PCa is associated with an aggressive phenotype and poor survival rates [11], CXCR4 expression correlates with increasing tumor aggressiveness, and PCa metastases display elevated CXCR4 levels compared with primary tumors [9]. The gene discussed is CXCR4; the disease is posterior cortical atrophy.